These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 30786729)
1. Identification of Potential Key Genes and Pathways in Early-Onset Colorectal Cancer Through Bioinformatics Analysis. Zhao B; Baloch Z; Ma Y; Wan Z; Huo Y; Li F; Zhao Y Cancer Control; 2019; 26(1):1073274819831260. PubMed ID: 30786729 [TBL] [Abstract][Full Text] [Related]
2. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
3. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
5. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis. Yu C; Chen F; Jiang J; Zhang H; Zhou M Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250 [TBL] [Abstract][Full Text] [Related]
6. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411 [TBL] [Abstract][Full Text] [Related]
7. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis. Yang Q; Li K; Li X; Liu J Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167 [No Abstract] [Full Text] [Related]
8. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer. Yang ZQ; Liu YJ; Zhou XL Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation. Liu YM; Yang TC; Fang XC; Yang LJ; Shi LW; Wang HQ; Dou TT; Shu L; Chen TL; Hu J; Yu XM; Li XF Curr Med Sci; 2024 Jun; 44(3):529-544. PubMed ID: 38809379 [TBL] [Abstract][Full Text] [Related]
10. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454 [TBL] [Abstract][Full Text] [Related]
11. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326 [TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
13. Identification of Potential Hub Genes and Signal Pathways Promoting the Distinct Biological Features of Cord Blood-Derived Endothelial Progenitor Cells Via Bioinformatics. Wang Q; Chen S; Wu J; Liu D; Jiang N; Wang B; Zhai J; Liu Z Genet Test Mol Biomarkers; 2020 Sep; 24(9):549-561. PubMed ID: 32744910 [No Abstract] [Full Text] [Related]
14. Screening of hub genes and pathways in colorectal cancer with microarray technology. Wang Y; Zheng T Pathol Oncol Res; 2014 Jul; 20(3):611-8. PubMed ID: 24504536 [TBL] [Abstract][Full Text] [Related]
15. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis. Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer. Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687 [TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer. Qi Y; Qi H; Liu Z; He P; Li B J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359 [TBL] [Abstract][Full Text] [Related]
18. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics. Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978 [TBL] [Abstract][Full Text] [Related]
19. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Wan Z; Zhang X; Luo Y; Zhao B Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428 [No Abstract] [Full Text] [Related]
20. Integrated analysis of intestinal microbiota and host gene expression in colorectal cancer patients. Chen Y; Si H; Bao B; Li S; Teng D; Yan Y; Hu S; Xu Y; Du X J Med Microbiol; 2022 Sep; 71(9):. PubMed ID: 36136380 [No Abstract] [Full Text] [Related] [Next] [New Search]